Abstract
ABSTRACT We have investigated the effects of Nef on infectivity in the context of various viral envelope proteins. These experiments were performed with a minimal vector system where Nef is the only accessory protein present. Our results support the hypothesis that the route of entry influences the ability of Nef to enhance human immunodeficiency virus (HIV) infectivity. We show that HIV particles pseudotyped with Ebola virus glycoprotein or vesicular stomatitis virus glycoprotein (VSV-G), which fuse at low pH, do not require Nef for optimal infectivity. In contrast, Nef significantly enhances the infectivity of virus particles that contain envelope proteins that fuse at neutral pH (CCR5-dependent HIV Env, CXCR4-dependent HIV Env, or amphotropic murine leukemia virus Env). In addition, our results demonstrate that virus particles containing mixed CXCR4-dependent HIV and VSV-G envelope proteins show a conditional requirement for Nef for optimal infectivity, depending on which protein is allowed to facilitate entry.
References
39
Referenced
85
10.1128/jvi.71.8.5871-5877.1997
10.1128/jvi.69.8.5048-5056.1995
10.1016/S0092-8674(00)80070-7
10.1073/pnas.85.21.7972
10.1128/jvi.71.2.1013-1018.1997
10.1016/0092-8674(90)90089-W
10.1128/jvi.74.10.4933-4937.2000
10.1006/viro.1995.1502
10.1128/jvi.68.5.2906-2914.1994
10.1038/381661a0
10.1016/S0960-9822(00)00654-0
10.1126/science.272.5263.872
10.1128/mcb.5.11.3231-3240.1985
- Grewe C. Beck A. Gelderblom H. R. HIV: early virus-cell interactions.J Acquir. Immune Defic. Syndr. 3 1990 965 974 / J Acquir. Immune Defic. Syndr. / HIV: early virus-cell interactions by Grewe C. (1990)
10.1128/jvi.66.4.2232-2239.1992
10.1128/JVI.73.10.8824-8830.1999
10.1128/jvi.65.1.162-169.1991
10.1128/jvi.64.4.1690-1697.1990
10.1006/viro.1997.8966
10.1242/jcs.110.1.95
10.1016/0022-2836(82)90269-8
10.1099/0022-1317-71-4-767
10.1016/0966-842X(94)90007-8
10.1084/jem.179.1.101
10.1128/jvi.69.1.579-584.1995
10.1126/science.272.5259.263
10.1128/jvi.70.7.4283-4290.1996
10.1083/jcb.107.3.959
10.1128/jvi.67.5.2681-2688.1993
10.1128/jvi.69.7.4053-4059.1995
10.1128/jvi.71.8.5841-5848.1997
10.1016/0092-8674(87)90542-3
10.1016/S0021-9258(18)45829-2
10.1006/viro.1996.0240
10.1128/JVI.72.4.3155-3160.1998
10.1038/nm0198-037
10.1021/bi00360a034
10.1126/science.279.5353.1034
10.1016/S0021-9258(19)47429-2
Dates
Type | When |
---|---|
Created | 23 years, 1 month ago (July 27, 2002, 5:55 a.m.) |
Deposited | 3 years, 5 months ago (March 5, 2022, 1:50 a.m.) |
Indexed | 1 year, 1 month ago (July 14, 2024, 6:13 p.m.) |
Issued | 24 years, 4 months ago (April 15, 2001) |
Published | 24 years, 4 months ago (April 15, 2001) |
Published Print | 24 years, 4 months ago (April 15, 2001) |
@article{Chazal_2001, title={Human Immunodeficiency Virus Type 1 Particles Pseudotyped with Envelope Proteins That Fuse at Low pH No Longer Require Nef for Optimal Infectivity}, volume={75}, ISSN={1098-5514}, url={http://dx.doi.org/10.1128/jvi.75.8.4014-4018.2001}, DOI={10.1128/jvi.75.8.4014-4018.2001}, number={8}, journal={Journal of Virology}, publisher={American Society for Microbiology}, author={Chazal, Nathalie and Singer, Gregory and Aiken, Christopher and Hammarskjöld, Marie-Louise and Rekosh, David}, year={2001}, month=apr, pages={4014–4018} }